skip to main | skip to sidebar

((( BAD MEDICINE )))

The Latest News about Defective Pharmaceuticals and Medical Devices. Sponsored by the law firm of Audet & Partners, LLP.

Wednesday, November 03, 2004

Kevin, M.D. - Medical Weblog: Merck withdraws Vioxx

Kevin, M.D. - Medical Weblog: Merck withdraws Vioxx
Posted by K.T. at 1:40 PM
Newer Post Older Post Home

Followers

Blog Archive

  • ►  2026 (17)
    • ►  April (2)
    • ►  March (9)
    • ►  February (6)
  • ►  2025 (16)
    • ►  November (1)
    • ►  May (8)
    • ►  April (1)
    • ►  March (2)
    • ►  February (3)
    • ►  January (1)
  • ►  2024 (24)
    • ►  November (4)
    • ►  May (4)
    • ►  April (3)
    • ►  February (4)
    • ►  January (9)
  • ►  2023 (6)
    • ►  December (4)
    • ►  January (2)
  • ►  2022 (3)
    • ►  August (1)
    • ►  January (2)
  • ►  2017 (3)
    • ►  June (1)
    • ►  February (1)
    • ►  January (1)
  • ►  2013 (1)
    • ►  July (1)
  • ►  2010 (7)
    • ►  March (4)
    • ►  February (3)
  • ►  2009 (9)
    • ►  April (4)
    • ►  March (1)
    • ►  January (4)
  • ►  2008 (18)
    • ►  October (1)
    • ►  May (3)
    • ►  April (2)
    • ►  March (12)
  • ►  2007 (3)
    • ►  March (1)
    • ►  January (2)
  • ►  2006 (47)
    • ►  December (5)
    • ►  October (4)
    • ►  May (1)
    • ►  April (20)
    • ►  March (10)
    • ►  February (7)
  • ►  2005 (85)
    • ►  November (7)
    • ►  September (3)
    • ►  August (13)
    • ►  July (5)
    • ►  June (10)
    • ►  May (8)
    • ►  April (12)
    • ►  March (4)
    • ►  February (5)
    • ►  January (18)
  • ▼  2004 (93)
    • ►  December (25)
    • ▼  November (53)
      • What Next? Former Vioxx users have several options
      • Merck Demands Specific Proof in Vioxx Suits, Court...
      • Merck to Award Hefty Severance in Event of Merger
      • FDA Interfered With Vioxx Article Publication
      • You Want A Moral Issue? How About Drugs That Don’t...
      • Merck execs protected in case of takeover
      • Big pharma haunted by the spectre of Pinto
      • Fool.com: 5 Drugs to Worry About?
      • Lessons From The Vioxx Fiasco
      • NPR : Drugs' Safety Questioned in Hearing on FDA
      • VIOXX HEARINGS: GET A TASTE OF YOUR OWN MEDICINE
      • Merck steps up PR campaign after recall
      • Betterhumans > Heart Finding Raises More COX-2 Con...
      • Study Suggests How COX Drugs Cause Heart Disease
      • The Murky History of Merck's Vioxx
      • Early Vioxx Alarms Alleged
      • Forbes.com: Say No To (Prescription) Drugs
      • Merck Strikes Back: Episode II
      • Gilmartin Strikes Back
      • HoustonChronicle.com - Vioxx maker nixed heart stu...
      • Reuters AlertNet - Merck knew Vioxx was unsafe by ...
      • "Ethical Bottom Feeder"
      • NPR : Merck Faces Proliferating Lawsuits over Vioxx
      • Merck Runs Full Page Ads in WSJ & NYT
      • MSNBC - CEO defends Merck on Vioxx heart dangers
      • You know it's a bad day when...
      • The Vioxx Board - Questions, Answers, and Discussi...
      • "Ethics is all about behavior"
      • Opinion: Vioxx: A case against tort reform
      • Minimizing the Mess at Merck
      • Merck Loses AAA Rating
      • Drug Ads -- Without Harmful Side Effects
      • MERCK & CO. INC. (Quarterly Report - SEC Filing)
      • Criminal Probe?
      • Editorial: Vioxx and veracity
      • Crisis Management - Crisis Public Relations
      • Merck v. The Lancet
      • Vioxx's Fall No Surprise to Some Doctors
      • Vioxx suits could be bitter pill for Merck
      • The Five Dumbest Things on Wall Street This Week
      • Guardian Unlimited | The Guardian | Drug giant 'ig...
      • FDA Indicates Vioxx Might Have Contributed to Abou...
      • That is not going win them any points with a jury...
      • Corante > In the Pipeline > Let's See What the Sha...
      • RangelMD.com (Merck Pulls Vioxx from Market)
      • Kevin, M.D. - Medical Weblog: Merck withdraws Vioxx
      • Yahoo! News - Report: Merck Tried to Bury Vioxx Co...
      • Vioxx vs. Naproxin
      • Easy on the Stomach, but at What Price?
      • S&P: Merck on Watch for Debt Downgrade
      • NPR : Report Finds Merck Hid Vioxx Concerns
      • FDA Concluded there were "Increased Risks" back in...
      • A Product Liability Nightmare
    • ►  October (13)
    • ►  September (2)

Contact Our Firm

  • Heparin.AudetLaw.com
  • Raptiva.AudetLaw.com
  • Depakote.AudetLaw.com
  • Chantix.AudetLaw.com
  • Fentanyl.AudetLaw.com
  • Avandia.AudetLaw.com
  • Gadolinium.AudetLaw.com
  • OrthoEvra.AudetLaw.com
  • Fosamax.AudetLaw.com

Contact Our Firm

  • 1.800.965.1461